IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

Tarik Asselah, Simon De Muynck, Philippe Broët, +16

Journal of Hepatology

Il28b PolymorphismAutoimmune DiseaseHepatitis CHepatologyViral Hepatitis +9

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients

Michelle Martinot-Peignoux, Roberto José de Carvalho‐Filho, Martine Lapalus, +6

Journal of Hepatology

FibrosisHepatologyAutoimmune DiseaseViral HepatitisImmunology +13

<scp>HB</scp>sAg quantification: useful for monitoring natural history and treatment outcome

Martine Lapalus, Tarik Asselah, Patrick Marcellin

Liver International

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA

Michelle Martinot-Peignoux, Martine Lapalus, Cédric Laouenan, +7

Journal of Clinical Virology

Baseline Serum MeasurementsAutoimmune DiseaseHepatologyViral HepatitisAsymptomatic Hepatitis B +8

Baseline HBsAg and HBcrAg titres allow peginterferon‐based ‘precision medicine’ in HBeAg‐negative chronic hepatitis B patients

Michèle Martinot‐Peignoux, Martine Lapalus, Sarah Maylin, +7

Journal of Viral Hepatitis

MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C

Kevin Appourchaux, Safi Dokmak, Matthieu Resche‐Rigon, +12

Scientific Reports

Microrna-based Diagnostic ToolsImmunologyPathologyChronic Hepatitis BCirrhosis +17

Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency

Elodie Mareux, Martine Lapalus, Rachida Amzal, +10

Liver International

Reduction of MicroRNA 122 Expression in <i>IFNL3</i> CT/TT Carriers and during Progression of Fibrosis in Patients with Chronic Hepatitis C

Emilie Estrabaud, Martine Lapalus, Philippe Broët, +10

Journal of Virology

<scp>IFNL</scp>3 (<scp>IL</scp>28B) polymorphism does not predict long‐term response to interferon therapy in <scp>HB</scp>eAg‐positive chronic hepatitis B patients

Q. Zhang, Martine Lapalus, Tarik Asselah, +11

Journal of Viral Hepatitis

Precore/Core promoter variants to predict significant fibrosis in both <scp>HB</scp>eAg positive and negative chronic hepatitis B

Martine Lapalus, Cédric Laouenan, Ana Carolina Cardoso, +11

Liver International